Back

Long-term treatment with LCZ696 (sacubitril/valsartan) improves cardiac and renal function in stroke-prone spontaneously hypertensive rats

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Hypertension treatment old and new Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Yoshiyu Takeda

Kanazawa Medical University, Uchinada (Japan)

9 More presentations in this session

Presentation thumbnail
Rates of adherence to modern antihypertensive drugs in resistant hypertension
Doctor E. Kocianova (Olomouc, CZ)
Abstract Slides
Presentation thumbnail
Non-steroid anti-inflammatory drug consumption decrease antihypertensive treatment efficacy in postenopausal women
Professor N. Izmozherova (Yekaterinburg, RU)
Abstract
Presentation thumbnail
Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients
Doctor A. Farcas (Cluj Napoca, RO)
Abstract
Presentation thumbnail
Effect of perindopril/indapamide/amlodipine fixed-dose combination on peripheral and central hemodynamics and vascular wall stiffness parameters in patients with uncontrolled hypertension
Doctor T. Netchessova (Minsk, BY)
Abstract Slides
Presentation thumbnail
CHINA STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive Patients: A one-year registry (CHINA STATUS III)
Mr Z. Du (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Hypertension treatment old and new

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Hypertension and glucose

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources